4-(7,7-dimethylfluoreno[4,3-b][1]benzofuran-3-yl)-3-[2-ethenyl-3-[(Z)-prop-1-enyl]indol-1-yl]benzonitrile
C41H30N2O — CID 126596359
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(7,7-dimethylfluoreno[4,3-b][1]benzofuran-3-yl)-3-[2-ethenyl-3-[(Z)-prop-1-enyl]indol-1-yl]benzonitrile
4-(7,7-dimethylfluoreno[4,3-b][1]benzofuran-3-yl)-3-[2-ethenyl-3-[(Z)-prop-1-enyl]indol-1-yl]benzonitrile (PubChem CID 126596359) has the molecular formula C41H30N2O and a molecular weight of 566.70 g/mol. Its IUPAC name is 4-(7,7-dimethylfluoreno[4,3-b][1]benzofuran-3-yl)-3-[2-ethenyl-3-[(Z)-prop-1-enyl]indol-1-yl]benzonitrile.
Molecular Properties
| Compound Name | 4-(7,7-dimethylfluoreno[4,3-b][1]benzofuran-3-yl)-3-[2-ethenyl-3-[(Z)-prop-1-enyl]indol-1-yl]benzonitrile |
|---|---|
| PubChem CID | 126596359 |
| Molecular Formula | C41H30N2O |
| Molecular Weight | 566.70 g/mol |
| Exact Mass | 566.24 |
| IUPAC Name | 4-(7,7-dimethylfluoreno[4,3-b][1]benzofuran-3-yl)-3-[2-ethenyl-3-[(Z)-prop-1-enyl]indol-1-yl]benzonitrile |
| SMILES | C=Cc1c(/C=C\C)c2ccccc2n1-c1cc(C#N)ccc1-c1ccc2oc3c4c(ccc3c2c1)C(C)(C)c1ccccc1-4 |
| InChI | InChI=1S/C41H30N2O/c1-5-11-28-29-12-8-10-15-36(29)43(35(28)6-2)37-22-25(24-42)16-18-27(37)26-17-21-38-32(23-26)30-19-20-34-39(40(30)44-38)31-13-7-9-14-33(31)41(34,3)4/h5-23H,2H2,1,3-4H3/b11-5- |
| InChIKey | PBVJVRDLKWWYMP-WZUFQYTHSA-N |
| XLogP | 11.05 |
| TPSA | 41.86 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 566.70 |
| LogP ≤ 5 | 11.05 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126596359 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.